Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study 2019-07-04 21:05
NeuroVive Receives Positive FDA Feedback on its NeuroSTAT TBI Development Plan 2018-09-06 15:10
Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ) 2018-05-31 20:09
NeuroVive and Yungjin Reports Positive KL1333 Phase I Clinical Study Results Paving the way for Further Clinical Development 2018-05-21 17:26
NeuroVive's KL1333 Receives FDA Orphan Drug Designation for Treatment of Mitochondrial Diseases 2018-04-18 15:57
NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment 2018-04-17 15:03
NeuroVive Decides on a Rights Issue for Continued Drug Development 2018-02-15 16:18
NeuroVive to Present at the 10th Annual Biotech Showcase Conference 2018-01-03 16:10
NeuroVive Board Chair Resigns, New Chair Elected 2017-11-07 15:55
NeuroVive Conducts a Directed New Share Issue of SEK 5.3 Million 2017-11-03 16:33
NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research 2017-10-18 15:05
NeuroVive Appoints Daniel Schale as Director of Communications 2017-10-04 15:00
1